Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2018 Volume 18 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2018 Volume 18 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing

  • Authors:
    • Xin‑Fu Lin
    • Jie‑Wei Luo
    • Gui Liu
    • Yao‑Bin Zhu
    • Zhao Jin
    • Xing Lin
  • View Affiliations / Copyright

    Affiliations: Provincial Clinical Medical College, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China, Department of Traditional Chinese Medicine, Fujian Provincial Hospital, Fuzhou, Fujian 350001, P.R. China, Department of Traditional Chinese Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350005, P.R. China
    Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4271-4280
    |
    Published online on: September 5, 2018
       https://doi.org/10.3892/mmr.2018.9455
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Dilated cardiomyopathy (DCM) is a complex myocardial disease of multifactorial etiologies, including enlarged cardiac chambers and contractile dysfunction. It has been suggested that the inheritance of DCM‑associated mutations predominates its onset. Therefore, the present study investigated the pathogenesis of DCM via pedigree analysis and genetic diagnosis by massive whole‑exome screening, and targeted exon capture. To study the familial gene‑phenotype association, the exon and splice sites of 325 hereditary disease‑associated genes in the proband with familial dilated cardiomyopathy (FDC), including 61 cardiac disease‑associated genes, such as the lamins A/C (LMNA), were analyzed by ultra‑high multiplex polymerase chain reaction and the Ion AmpliSeq™ Inherited Disease Panel. The present study also conducted Sanger DNA Sequencing for family members with global minor allele frequencies <1% to verify potential pathogenic mutation sites. A total of three rare missense mutations were detected, including heterozygous c.244G>A in LMNA, c.546C>G in potassium voltage‑gated channel subfamily KQT (KCNQ4) and c.1276G>A in EYA transcriptional coactivator and phosphatase 1 (EYA1), indicating a glutamic acid to lysine substitution at amino acid 82 (p.E82K) in LMNA, a p.F182L in KCNQ4 (a mutation associated with pathogenic deafness) and p.G426S in EYA1 (associated with Branchiootorenal syndrome 1 and Branchiootic syndrome 1 pathogenesis). In the present study, a carrier with slight hearing impairment was detected in the family analyzed; however, no patients with deafness or branchiootorenal syndrome were observed. LMNA p.E82K revealed SIFT and PolyPhen‑2 scores of 0 and 1, respectively. In the second generation, 3 patients with DCM underwent permanent pacemaker implantation due to sick sinus syndrome, atrioventricular block and unstable cardiac electrophysiology. The present study suggested that LMNA p.E82K may contribute to the pathogenesis of FDC and concomitant atrioventricular block. At present, only three families with DCM resulting from similar mutations have been reported. The present study demonstrated the strong pathogenic effects of LMNA p.E82K on DCM.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Hershberger RE and Siegfried JD: Update 2011: Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 57:1641–1649. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Hershberger RE, Hedges DJ and Morales A: Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat Rev Cardiol. 10:531–547. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Zahr HC and Jaalouk DE: Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy. Front Genet. 9:2312018. View Article : Google Scholar : PubMed/NCBI

4 

Skrzynia C, Berg JS, Willis MS and Jensen BC: Genetics and heart failure: A concise guide for the clinician. Curr Cardiol Rev. 11:10–17. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Yang J, Xu WW and Hu SJ: Heart failure: advanced development in genetics and epigenetics. Biomed Res Int. 2015:3527342015. View Article : Google Scholar : PubMed/NCBI

6 

Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A and Tavazzi L: Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease. J Am Coll Cardiol. 39:1–990. 2002. View Article : Google Scholar : PubMed/NCBI

7 

van Tintelen JP, Hofstra RM, Katerberg H, Rossenbacker T, Wiesfeld AC, du Marchie Sarvaas GJ, Wilde AA, van Langen IM, Nannenberg EA, van der Kooi AJ, et al: High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J. 154:1130–1139. 2007. View Article : Google Scholar : PubMed/NCBI

8 

van Spaendonck-Zwarts KY, van Rijsingen IA, van den Berg MP, Lekanne Deprez RH, Post JG, van Mil AM, Asselbergs FW, Christiaans I, van Langen IM, Wilde AA, et al: Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: Overview of 10 years' experience. Eur J Heart Fail. 15:628–636. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Hutchison CJ and Worman HJ: A-type lamins: guardians of the soma? Nat Cell Biol. 6:1062–1067. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Scaffidi P and Misteli T: Lamin A-dependent nuclear defects in human aging. Science. 312:1059–1063. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Al-Haboubi T, Shumaker DK, Köser J, Wehnert M and Fahrenkrog B: Distinct association of the nuclear pore protein Nup153 with A- and B-type lamins. Nucleus. 2:500–509. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Worman HJ and Bonne G: ‘Laminopathies’: A wide spectrum of human diseases. Exp Cell. 313:2121–2133. 2007. View Article : Google Scholar

13 

Freeman AR and Levine SA: Clinical significance of systolic murmurs: Study of 1000 consecutive ‘noncardiac’ cases. Ann Intern Med. 6:1371–1379. 1933. View Article : Google Scholar

14 

Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A and Komajda M: Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the European human and capital. mobility project on familial dilated cardiomyopathy. Eur Heart J. 20:93–102. 1999. View Article : Google Scholar : PubMed/NCBI

15 

AHA Medical/Scientific Statement, . 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation. 90:644–645. 1994.PubMed/NCBI

16 

Li Z, Huang J, Zhao J, Chen C, Wang H, Ding H and Wang DW and Wang DW: Rapid molecular genetic diagnosis of hypertrophic cardiomyopathy by semiconductor sequencing. J Transl Med. 12:1732014. View Article : Google Scholar : PubMed/NCBI

17 

1000 GenomesProject Consortium, ; Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT and McVean GA: An integrated map of genetic variation from 1,092 human genomes. Nature. 491:56–65. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Smith RJH and Hildebrand M: DFNA2 Nonsyndromic Hearing LossGeneReviews® [Internet]. Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH and Stephens K: University of Washington; Seattle, WA: pp. 1993–2016. 2008

19 

Su CC, Yang JJ, Shieh JC, Su MC and Li SY: Identification of novel mutations in the KCNQ4 gene of patients with nonsyndromic deafness from Taiwan. Audiol Neurootol. 12:20–26. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Azuma N, Hirakiyama A, Inoue T, Asaka A and Yamada M: Mutations of a human homologue of the Drosophila eyes absent gene (EYA1) detected in patients with congenital cataracts and ocular anterior segment anomalies. Hum Mol Genet. 9:363–366. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL and Burke B: Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol. 147:913–920. 1999. View Article : Google Scholar : PubMed/NCBI

22 

Jahn D, Schramm S, Schnölzer M, Heilmann CJ, de Koster CG, Schütz W, Benavente R and Alsheimer M: A truncated lamin A in the Lmna −/− mouse line: Implications for the understanding of laminopathies. Nucleus. 3:463–474. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Kubben N, Voncken JW, Konings G, van Weeghel M, van den Hoogenhof MM, Gijbels M, van Erk A, Schoonderwoerd K, van den Bosch B, Dahlmans V, et al: Post-natal myogenic and adipogenic developmental: Defects and metabolic impairment upon loss of A-type lamins. Nucleus. 2:195–207. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Kang SM, Yoon MH and Park BJ: Laminopathies; Mutations on single gene and various human genetic diseases. BMB Rep. 51:327–337. 2018. View Article : Google Scholar : PubMed/NCBI

25 

McNally EM, Golbus JR and Puckelwartz MJ: Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 123:19–26. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Worman HJ, Ostlund C and Wang Y: Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol. 2:a0007602010. View Article : Google Scholar : PubMed/NCBI

27 

Bilińska ZT, Sylvius N, Grzybowski J, Fidziańska A, Michalak E, Walczak E, Walski M, Bieganowska K, Szymaniak E, Kuśmierczyk-Droszcz B, et al: Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies. Kardiol Pol. 64:812–821. 2006.PubMed/NCBI

28 

Sun LP, Wang L, Wang H, Zhang YH and Pu JL: Connexin 43 remodeling induced by LMNA gene mutation Glu82Lys in familial dilated cardiomyopathy with atrial ventricular block. Chin Med J (Engl). 123:1058–1062. 2010.PubMed/NCBI

29 

van Berlo JH, de Voogt WG, van der Kooi AJ, van Tintelen JP, Bonne G, Yaou RB, Duboc D, Rossenbacker T, Heidbüchel H, de Visser M, et al: Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl). 83:79–83. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM and Duboc D: Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med. 354:209–210. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Wu W, Shan J, Bonne G, Worman HJ and Muchir A: Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene. Biochim Biophys Acta. 1802:632–638. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Wu W, Muchir A, Shan J, Bonne G and Worman HJ: Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation. 123:53–61. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Mattout A, Pike BL, Towbin BD, Bank EM, Gonzalez-Sandoval A, Stadler MB, Meister P, Gruenbaum Y and Gasser SM: An EDMD mutation in C. elegans lamin blocks muscle-specific gene relocation and compromises muscle integrity. Curr Biol. 21:1603–1614. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Novelli G and D'Apice MR: The strange case of the ‘lumper’ lamin A/C gene and human premature ageing. Trends Mol Med. 9:370–375. 2003. View Article : Google Scholar : PubMed/NCBI

35 

Wang H, Zheng WY, Wang JZ, Wang XJ, Zhen YS, Song L, Zou YB and Hui RT: A novel LMNA gene mutation E82K associated with familial dilated cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi. 33:875–879. 2005.(In Chinese). PubMed/NCBI

36 

Wu X, Wang QK, Gui L, Liu M, Zhang X, Jin R, Li W, Yan L, Du R, Wang Q, et al: Identification of a new lamin A/C mutation in a Chinese family affected with atrioventricular block as the prominent phenotype. J Huazhong Univ Sci Technolog Med Sci. 30:103–107. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Wang H, Song XD, Wang SX, Fu CY, Sun K and Hui RT: Effects of a novel familial dilated cardiomyopathy associated LMNA gene mutation E82K on cell cycle of HEK293 cells. Zhonghua Xin Xue Guan Bing Za Zhi. 35:21–23. 2007.(In Chinese). PubMed/NCBI

38 

Lu D, Lian H, Zhang X, Shao H, Huang L, Qin C and Zhang L: LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice. PLoS One. 5:e151672010. View Article : Google Scholar : PubMed/NCBI

39 

Manrai AK, Ioannidis JP and Kohane IS: Clinical genomics: from pathogenicity claims to quantitative risk estimates. JAMA. 315:1233–1234. 2016. View Article : Google Scholar : PubMed/NCBI

40 

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL and Lebo MS: A systematic approach to assessing the clinical significance of genetic variants. Clin Genet. 84:453–463. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Severs NJ, Bruce AF, Dupont E and Rothery S: Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 80:9–19. 2008. View Article : Google Scholar : PubMed/NCBI

42 

Petrich BG, Eloff BC, Lerner DL, Kovacs A, Saffitz JE, Rosenbaum DS and Wang Y: Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem. 279:15330–15338. 2004. View Article : Google Scholar : PubMed/NCBI

43 

Cho JH, Cho SD, Hu H, Kim SH, Lee SK, Lee YS and Kang KS: The roles of ERK1/2 and p38 MAP kinases in the preventive mechanisms of mushroom Phellinus linteus against the inhibition of gap junctional intercellular communication by hydrogen peroxide. Carcinogenesis. 23:1163–1169. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Muchir A, Shan J, Bonne G, Lehnart SE and Worman HJ: Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet. 18:241–247. 2009. View Article : Google Scholar : PubMed/NCBI

45 

Wang H, Wang J, Zheng W, Wang X, Wang S, Song L, Zou Y, Yao Y and Hui R: Mutation Glu82Lys in lamin A/C gene is associated with cardiomyopathy and conduction defect. Biochem Biophys Res Commun. 344:17–24. 2006. View Article : Google Scholar : PubMed/NCBI

46 

Wang H, Zheng WY, Wang JZ, Song L, Zou YB, Zhen YS, Wang XJ and Hui RT: The effect of cell mitosis of LMNA gene mutation E82K associated with familial dilated cardiomyopathy. Mol Cardiol China. 5:777–779. 2005.

47 

Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poon S, McKeown P, Davies RA, Chan KL, Tang AS, et al: In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet. 42:639–647. 2005. View Article : Google Scholar : PubMed/NCBI

48 

Malhotra R and Mason PK: Lamin A/C deficiency as a cause of familial dilated cardiomyopathy. Curr Opin Cardiol. 24:203–208. 2009. View Article : Google Scholar : PubMed/NCBI

49 

Małek LA, Labib S, Mazurkiewicz L, Saj M, Płoski R, Tesson F and Bilińska ZT: A new c C > G, p.R541G lamin A/C mutation in a family with DCM and regional wall motion abnormalities (akinesis/dyskinesis): Genotype-phenotype correlation. J Hum Genet. 56:83–86. 2011. View Article : Google Scholar : PubMed/NCBI

50 

Şahan E, Şahan S, Karamanlıoğlu M, Gul M and Tufekcioğlu O: The MOGE(S) classification: A TNM-like classification for cardiomyopathies. Herz. 41:503–506. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lin XF, Luo JW, Liu G, Zhu YB, Jin Z and Lin X: Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing. Mol Med Rep 18: 4271-4280, 2018.
APA
Lin, X., Luo, J., Liu, G., Zhu, Y., Jin, Z., & Lin, X. (2018). Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing. Molecular Medicine Reports, 18, 4271-4280. https://doi.org/10.3892/mmr.2018.9455
MLA
Lin, X., Luo, J., Liu, G., Zhu, Y., Jin, Z., Lin, X."Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing". Molecular Medicine Reports 18.5 (2018): 4271-4280.
Chicago
Lin, X., Luo, J., Liu, G., Zhu, Y., Jin, Z., Lin, X."Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing". Molecular Medicine Reports 18, no. 5 (2018): 4271-4280. https://doi.org/10.3892/mmr.2018.9455
Copy and paste a formatted citation
x
Spandidos Publications style
Lin XF, Luo JW, Liu G, Zhu YB, Jin Z and Lin X: Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing. Mol Med Rep 18: 4271-4280, 2018.
APA
Lin, X., Luo, J., Liu, G., Zhu, Y., Jin, Z., & Lin, X. (2018). Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing. Molecular Medicine Reports, 18, 4271-4280. https://doi.org/10.3892/mmr.2018.9455
MLA
Lin, X., Luo, J., Liu, G., Zhu, Y., Jin, Z., Lin, X."Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing". Molecular Medicine Reports 18.5 (2018): 4271-4280.
Chicago
Lin, X., Luo, J., Liu, G., Zhu, Y., Jin, Z., Lin, X."Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing". Molecular Medicine Reports 18, no. 5 (2018): 4271-4280. https://doi.org/10.3892/mmr.2018.9455
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team